Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease

被引:22
|
作者
Kapogiannis, Dimitrios [2 ]
Mattson, Mark P. [1 ]
机构
[1] NIA, Neurosci Lab, Biomed Res Ctr, Intramural Res Program, Baltimore, MD 21224 USA
[2] NIA, Clin Res Branch, Intramural Res Program, Baltimore, MD 21224 USA
来源
LANCET NEUROLOGY | 2011年 / 10卷 / 02期
基金
美国国家卫生研究院;
关键词
AMYLOID-BETA-PEPTIDE; TRANSGENIC MOUSE MODEL; A-BETA; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; DIETARY RESTRICTION; IMPROVES COGNITION; PHYSICAL-ACTIVITY; FUNCTIONAL CONNECTIVITY; HIPPOCAMPAL FUNCTION;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Epidemiological, neuropathological, and functional neuroimaging evidence implicates global and regional disruptions in brain metabolism and energetics in the pathogenesis of cognitive impairment. Nerve cell microcircuits are modified by excitatory and inhibitory synaptic activity and neurotrophic factors. Ageing and Alzheimer's disease cause perturbations in cellular energy metabolism, level of excitation or inhibition, and neurotrophic factor release, which overwhelm compensatory mechanisms and result in dysfunction of neuronal microcircuits and brain networks. A prolonged positive energy balance impairs the ability of neurons to adapt to oxidative and metabolic stress. Results from experimental studies in animals show how disruptions caused by chronic positive energy balance, such as diabetes, lead to accelerated cognitive ageing and Alzheimer's disease. Therapeutic interventions to allay cognitive dysfunction that target energy metabolism and adaptive stress responses (such as neurotrophin signalling) have been effective in animal models and in preliminary studies in humans.
引用
收藏
页码:187 / 198
页数:12
相关论文
共 50 条
  • [21] Energy metabolism, oxidative stress and neuronal degeneration in Alzheimer's disease
    Sims, NR
    [J]. NEURODEGENERATION, 1996, 5 (04): : 435 - 440
  • [22] Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease
    Morrone, Christopher Daniel
    Raghuraman, Radha
    Hussaini, S. Abid
    Yu, Wai Haung
    [J]. MOLECULAR NEURODEGENERATION, 2023, 18 (01)
  • [23] Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
    Christopher Daniel Morrone
    Radha Raghuraman
    S. Abid Hussaini
    Wai Haung Yu
    [J]. Molecular Neurodegeneration, 18
  • [24] Alzheimer's disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment
    Chen, Ping-Chung
    Han, Xian
    Shaw, Timothy I.
    Fu, Yingxue
    Sun, Huan
    Niu, Mingming
    Wang, Zhen
    Jiao, Yun
    Teubner, Brett J. W.
    Eddins, Donnie
    Beloate, Lauren N.
    Bai, Bing
    Mertz, Joseph
    Li, Yuxin
    Cho, Ji-Hoon
    Wang, Xusheng
    Wu, Zhiping
    Liu, Danting
    Poudel, Suresh
    Yuan, Zuo-Fei
    Mancieri, Ariana
    Low, Jonathan
    Lee, Hyeong-Min
    Patton, Mary H.
    Earls, Laurie R.
    Stewart, Elizabeth
    Vogel, Peter
    Hui, Yawei
    Wan, Shibiao
    Bennett, David A.
    Serrano, Geidy E.
    Beach, Thomas G.
    Dyer, Michael A.
    Smeyne, Richard J.
    Moldoveanu, Tudor
    Chen, Taosheng
    Wu, Gang
    Zakharenko, Stanislav S.
    Yu, Gang
    Peng, Junmin
    [J]. NATURE AGING, 2022, 2 (10): : 923 - +
  • [25] Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment
    Ping-Chung Chen
    Xian Han
    Timothy I. Shaw
    Yingxue Fu
    Huan Sun
    Mingming Niu
    Zhen Wang
    Yun Jiao
    Brett J. W. Teubner
    Donnie Eddins
    Lauren N. Beloate
    Bing Bai
    Joseph Mertz
    Yuxin Li
    Ji-Hoon Cho
    Xusheng Wang
    Zhiping Wu
    Danting Liu
    Suresh Poudel
    Zuo-Fei Yuan
    Ariana Mancieri
    Jonathan Low
    Hyeong-Min Lee
    Mary H. Patton
    Laurie R. Earls
    Elizabeth Stewart
    Peter Vogel
    Yawei Hui
    Shibiao Wan
    David A. Bennett
    Geidy E. Serrano
    Thomas G. Beach
    Michael A. Dyer
    Richard J. Smeyne
    Tudor Moldoveanu
    Taosheng Chen
    Gang Wu
    Stanislav S. Zakharenko
    Gang Yu
    Junmin Peng
    [J]. Nature Aging, 2022, 2 : 923 - 940
  • [26] Alzheimer's Disease and mild cognitive impairment
    Kelley, Brendan J.
    Petersen, Ronald C.
    [J]. NEUROLOGIC CLINICS, 2007, 25 (03) : 577 - +
  • [27] Nutraceuticals in cognitive impairment and Alzheimer's disease
    Mecocci, P.
    Tinarelli, C.
    Schulz, R. J.
    Polidori, M. C.
    [J]. FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [28] Apathy and executive dysfunction in mild cognitive impairment and in Alzheimer disease
    Ready, RE
    Ott, BR
    Grace, J
    Cahn-Weiner, DA
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 11 (02): : 222 - 228
  • [29] Mild cognitive impairment: Is it Alzheimer's disease or not?
    Petersen, RC
    Bennett, D
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2005, 7 (03) : 241 - 245
  • [30] Cognitive impairment in Alzheimer's disease and schizophrenia
    Hoblyn, J
    Marin, D
    Harvey, PD
    Mohs, RC
    Davis, KL
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 : 111S - 111S